|
SENP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.704200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.567800E-01 |
| Normal-vs-Stage2 |
9.750200E-02 |
| Normal-vs-Stage3 |
1.152920E-04 |
| Normal-vs-Stage4 |
2.584000E-03 |
| Stage1-vs-Stage2 |
1.899390E-01 |
| Stage1-vs-Stage3 |
1.441460E-03 |
| Stage1-vs-Stage4 |
1.443700E-02 |
| Stage2-vs-Stage3 |
3.698600E-01 |
| Stage2-vs-Stage4 |
5.483400E-01 |
| Stage3-vs-Stage4 |
7.864600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.563100E-03 |
| Normal-vs-AfricanAmerican |
2.811500E-02 |
| Normal-vs-Asian |
2.392000E-01 |
| Caucasian-vs-AfricanAmerican |
5.212800E-01 |
| Caucasian-vs-Asian |
9.363400E-01 |
| AfricanAmerican-vs-Asian |
8.557200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.3673999999958E-05 |
| Normal-vs-Female |
7.489600E-01 |
| Male-vs-Female |
6.789000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.228020E-01 |
| Normal-vs-Age(41-60Yrs) |
6.272300E-02 |
| Normal-vs-Age(61-80Yrs) |
4.482500E-03 |
| Normal-vs-Age(81-100Yrs) |
7.338200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.000800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.164400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.032000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.001000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.632600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.749200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.647000E-01 |
| Normal-vs-Grade 2 |
4.895200E-01 |
| Normal-vs-Grade 3 |
2.384500E-04 |
| Normal-vs-Grade 4 |
3.038600E-04 |
| Grade 1-vs-Grade 2 |
2.393400E-01 |
| Grade 1-vs-Grade 3 |
2.094200E-02 |
| Grade 1-vs-Grade 4 |
1.359520E-02 |
| Grade 2-vs-Grade 3 |
2.679300E-03 |
| Grade 2-vs-Grade 4 |
8.403300E-04 |
| Grade 3-vs-Grade 4 |
1.886790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.797400E-01 |
| Normal-vs-ccB subtype |
9.64690000000434E-05 |
| ccA subtype-vs-ccB subtype |
1.74050000001369E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.164000E-02 |
| Normal-vs-N1 |
2.007500E-02 |
| N0-vs-N1 |
1.101230E-01 |
|
|
